KRAS and cancer: Although the KRAS protein is closely associated with cancer, recent studies have shown that the KRAS protein can cause oncogenic mutations around activation sites (e.g., G12C, G12D, etc.), leading to downstream RAFs and overexpression of PI3K proteins.